Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Identification and Characterization of Circulating Naïve CD4+ and CD8+ T Cells Recognizing Nickel.

Bechara R, Pollastro S, Azoury ME, Szely N, Maillère B, de Vries N, Pallardy M.

Front Immunol. 2019 Jun 12;10:1331. doi: 10.3389/fimmu.2019.01331. eCollection 2019.

2.

Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection.

Azam A, Gallais Y, Mallart S, Illiano S, Duclos O, Prades C, Maillère B.

J Immunol. 2019 Jun 15;202(12):3507-3513. doi: 10.4049/jimmunol.1800856. Epub 2019 May 17.

PMID:
31101669
3.

Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques.

Bitoun S, Roques P, Maillere B, Le Grand R, Mariette X.

Ann Rheum Dis. 2019 Jul;78(7):917-921. doi: 10.1136/annrheumdis-2019-215114. Epub 2019 Apr 25.

PMID:
31023654
4.

Identification and characterization of a naïve CD8+ T cell repertoire for benzylpenicillin.

Bechara R, Maillere B, Joseph D, Weaver RJ, Pallardy M.

Clin Exp Allergy. 2019 May;49(5):636-643. doi: 10.1111/cea.13338. Epub 2019 Feb 8.

PMID:
30657219
5.

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes.

Onodi F, Maherzi-Mechalikh C, Mougel A, Ben Hamouda N, Taboas C, Gueugnon F, Tran T, Nozach H, Marcon E, Gey A, Terme M, Bouzidi A, Maillere B, Kerzerho J, Tartour E, Tanchot C.

Front Oncol. 2018 Nov 13;8:517. doi: 10.3389/fonc.2018.00517. eCollection 2018.

6.

Fab is the most efficient format to express functional antibodies by yeast surface display.

Sivelle C, Sierocki R, Ferreira-Pinto K, Simon S, Maillere B, Nozach H.

MAbs. 2018 Jul;10(5):720-729. doi: 10.1080/19420862.2018.1468952. Epub 2018 May 24.

7.

Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes.

Nithichanon A, Rinchai D, Buddhisa S, Saenmuang P, Kewcharoenwong C, Kessler B, Khaenam P, Chetchotisakd P, Maillere B, Robinson J, Reynolds CJ, Boyton RJ, Altmann DM, Lertmemongkolchai G.

Front Immunol. 2018 Mar 20;9:484. doi: 10.3389/fimmu.2018.00484. eCollection 2018.

8.

Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab.

Spindeldreher S, Maillère B, Correia E, Tenon M, Karle A, Jarvis P, Kolbinger F.

Dermatol Ther (Heidelb). 2018 Jun;8(2):327. doi: 10.1007/s13555-018-0234-5.

9.

Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab.

Spindeldreher S, Maillère B, Correia E, Tenon M, Karle A, Jarvis P, Kolbinger F.

Dermatol Ther (Heidelb). 2018 Mar;8(1):57-68. doi: 10.1007/s13555-018-0220-y. Epub 2018 Feb 1. Erratum in: Dermatol Ther (Heidelb). 2018 Mar 17;:.

10.

Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy.

Azoury ME, Filì L, Bechara R, Scornet N, de Chaisemartin L, Weaver RJ, Claude N, Maillere B, Parronchi P, Joseph D, Pallardy M.

Allergy. 2018 Aug;73(8):1662-1672. doi: 10.1111/all.13418. Epub 2018 Feb 27.

PMID:
29355985
11.

T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.

Reynolds CJ, Suleyman OM, Ortega-Prieto AM, Skelton JK, Bonnesoeur P, Blohm A, Carregaro V, Silva JS, James EA, Maillère B, Dorner M, Boyton RJ, Altmann DM.

Sci Rep. 2018 Jan 12;8(1):672. doi: 10.1038/s41598-017-18781-1.

12.

CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naïve and memory cells.

Meunier S, Menier C, Marcon E, Lacroix-Desmazes S, Maillère B.

Blood Adv. 2017 Sep 25;1(21):1842-1847. doi: 10.1182/bloodadvances.2017008706. eCollection 2017 Sep 26.

13.

State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.

van Vliet E, Kühnl J, Goebel C, Martinozzi-Teissier S, Alépée N, Ashikaga T, Blömeke B, Del Bufalo A, Cluzel M, Corsini E, Delrue N, Desprez B, Gellatly N, Giese C, Gribaldo L, Hoffmann S, Klaric M, Maillere B, Naisbitt D, Pallardy M, Vocanson M, Petersohn D.

ALTEX. 2018;35(2):179-192. doi: 10.14573/altex.1709011. Epub 2017 Oct 2.

14.

The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.

Gilardin L, Delignat S, Peyron I, Ing M, Lone YC, Gangadharan B, Michard B, Kherabi Y, Sharma M, Pashov A, Latouche JB, Hamieh M, Toutirais O, Loiseau P, Galicier L, Veyradier A, Kaveri S, Maillère B, Coppo P, Lacroix-Desmazes S.

Haematologica. 2017 Nov;102(11):1833-1841. doi: 10.3324/haematol.2015.136671. Epub 2017 Jul 27.

15.

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.

Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B.

Front Immunol. 2017 May 5;8:500. doi: 10.3389/fimmu.2017.00500. eCollection 2017.

16.

Monoepitopic anti-FVIII T-cell response.

Lacroix-Desmazes S, Maillere B.

Blood. 2016 Oct 20;128(16):1999-2001. doi: 10.1182/blood-2016-08-732123. No abstract available.

PMID:
28157675
17.

Bioinspired Design and Oriented Synthesis of Immunogenic Site-Specifically Penicilloylated Peptides.

Scornet N, Delarue-Cochin S, Azoury ME, Le Mignon M, Chemelle JA, Nony E, Maillère B, Terreux R, Pallardy M, Joseph D.

Bioconjug Chem. 2016 Nov 16;27(11):2629-2645. Epub 2016 Sep 9.

PMID:
27552359
18.

Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.

Laheurte C, Galaine J, Beziaud L, Dosset M, Kerzerho J, Jacquemard C, Gaugler B, Ferrand C, Dormoy A, Aubin F, Jacoulet P, Westeel V, Borg C, Tartour E, Godet Y, Maillère B, Adotévi O.

Oncoimmunology. 2016 Feb 18;5(5):e1137416. doi: 10.1080/2162402X.2015.1137416. eCollection 2016 May.

19.

Immunogenicity of tocilizumab in patients with rheumatoid arthritis.

Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C.

Joint Bone Spine. 2017 Jan;84(1):39-45. doi: 10.1016/j.jbspin.2016.04.013. Epub 2016 Jun 28.

PMID:
27369643
20.

BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data.

Boelen L, O'Neill PK, Quigley KJ, Reynolds CJ, Maillere B, Robinson JH, Lertmemongkolchai G, Altmann DM, Boyton RJ, Asquith B.

PLoS Comput Biol. 2016 Mar 8;12(3):e1004796. doi: 10.1371/journal.pcbi.1004796. eCollection 2016 Mar.

21.

CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor.

Ascough S, Ingram RJ, Chu KK, Musson JA, Moore SJ, Gallagher T, Baillie L, Williamson ED, Robinson JH, Maillere B, Boyton RJ, Altmann DM.

Front Microbiol. 2016 Jan 5;6:1506. doi: 10.3389/fmicb.2015.01506. eCollection 2015.

22.

Immunogenicity of long-lasting recombinant factor VIII products.

Ing M, Gupta N, Teyssandier M, Maillère B, Pallardy M, Delignat S, Lacroix-Desmazes S; ABIRISK consortium.

Cell Immunol. 2016 Mar;301:40-8. doi: 10.1016/j.cellimm.2015.12.006. Epub 2015 Dec 19. Review.

PMID:
26723503
23.

An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses.

de Wolf C, van der Zee R, den Braber I, Glant T, Maillère B, Favry E, van Lummel M, Koning F, Hoek A, Ludwig I, van Eden W, Broere F.

Arthritis Rheumatol. 2016 Mar;68(3):639-47. doi: 10.1002/art.39444.

24.

The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors.

Chevaleyre C, Benhamouda N, Favry E, Fabre E, Mhoumadi A, Nozach H, Marcon E, Cosler G, Vinatier E, Oudard S, Hans S, Le Pimpec-Barthes F, Bats AS, Castelli FA, Tartour E, Maillère B.

J Immunol. 2015 Aug 15;195(4):1891-901. doi: 10.4049/jimmunol.1402548. Epub 2015 Jul 1.

25.

Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines.

Ingram RJ, Ascough S, Reynolds CJ, Metan G, Doganay M, Baillie L, Williamson DE, Robinson JH, Maillere B, Boyton RJ, Altmann DM.

Cell Biosci. 2015 Apr 26;5:20. doi: 10.1186/s13578-015-0011-4. eCollection 2015.

26.

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F; ABIRISK Consortium.

Clin Exp Immunol. 2015 Sep;181(3):385-400. doi: 10.1111/cei.12652. Epub 2015 Jul 2. Review.

27.

T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.

Reynolds C, Goudet A, Jenjaroen K, Sumonwiriya M, Rinchai D, Musson J, Overbeek S, Makinde J, Quigley K, Manji J, Spink N, Yos P, Wuthiekanun V, Bancroft G, Robinson J, Lertmemongkolchai G, Dunachie S, Maillere B, Holden M, Altmann D, Boyton R.

J Immunol. 2015 May 15;194(10):4814-24. doi: 10.4049/jimmunol.1402862. Epub 2015 Apr 10.

28.

Characterization of human memory CD4(+) T-cell responses to the dog allergen Can f 4.

Rönkä AL, Kinnunen TT, Goudet A, Rytkönen-Nissinen MA, Sairanen J, Kailaanmäki AH, Randell JT, Maillère B, Virtanen TI.

J Allergy Clin Immunol. 2015 Oct;136(4):1047-54.e10. doi: 10.1016/j.jaci.2015.02.025. Epub 2015 Apr 3.

PMID:
25843313
29.

Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.

Quigley KJ, Reynolds CJ, Goudet A, Raynsford EJ, Sergeant R, Quigley A, Worgall S, Bilton D, Wilson R, Loebinger MR, Maillere B, Altmann DM, Boyton RJ.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1250-64. doi: 10.1164/rccm.201411-1995OC.

30.

Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.

Zuidmeer-Jongejan L, Huber H, Swoboda I, Rigby N, Versteeg SA, Jensen BM, Quaak S, Akkerdaas JH, Blom L, Asturias J, Bindslev-Jensen C, Bernardi ML, Clausen M, Ferrara R, Hauer M, Heyse J, Kopp S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maderegger B, Maillere B, Mari A, Martinez A, Mills EN, Neubauer A, Nicoletti C, Papadopoulos NG, Portoles A, Ranta-Panula V, Santos-Magadan S, Schnoor HJ, Sigurdardottir ST, Stahl-Skov P, Stavroulakis G, Stegfellner G, Vázquez-Cortés S, Witten M, Stolz F, Poulsen LK, Fernandez-Rivas M, Valenta R, van Ree R.

Int Arch Allergy Immunol. 2015;166(1):41-51. doi: 10.1159/000371657. Epub 2015 Feb 28.

31.

CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Musson JA, Reynolds CJ, Rinchai D, Nithichanon A, Khaenam P, Favry E, Spink N, Chu KK, De Soyza A, Bancroft GJ, Lertmemongkolchai G, Maillere B, Boyton RJ, Altmann DM, Robinson JH.

J Immunol. 2014 Dec 15;193(12):6041-9. doi: 10.4049/jimmunol.1402273. Epub 2014 Nov 12.

32.

The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.

Reynolds CJ, Jones C, Blohmke CJ, Darton TC, Goudet A, Sergeant R, Maillere B, Pollard AJ, Altmann DM, Boyton RJ.

Immunology. 2014 Nov;143(3):438-46. doi: 10.1111/imm.12327.

33.

Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other.

Liukko AL, Kinnunen TT, Rytkönen-Nissinen MA, Kailaanmäki AH, Randell JT, Maillère B, Virtanen TI.

PLoS One. 2014 May 29;9(5):e98461. doi: 10.1371/journal.pone.0098461. eCollection 2014.

34.

Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Ascough S, Ingram RJ, Chu KK, Reynolds CJ, Musson JA, Doganay M, Metan G, Ozkul Y, Baillie L, Sriskandan S, Moore SJ, Gallagher TB, Dyson H, Williamson ED, Robinson JH, Maillere B, Boyton RJ, Altmann DM.

PLoS Pathog. 2014 May 1;10(5):e1004085. doi: 10.1371/journal.ppat.1004085. eCollection 2014 May.

35.

Injectional anthrax infection due to heroin use induces strong immunological memory.

Ascough S, Ingram RJ, Abarra A, Holmes AJ, Maillere B, Altmann DM, Boyton RJ.

J Infect. 2014 Feb;68(2):200-3. No abstract available.

36.

Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation.

Till SJ, Raynsford EJ, Reynolds CJ, Quigley KJ, Grzybowska-Kowalczyk A, Saggar LR, Goldstone A, Maillere B, Kwok WW, Altmann DM, Durham SR, Boyton RJ.

Thorax. 2014 Apr;69(4):335-45. doi: 10.1136/thoraxjnl-2013-204324. Epub 2013 Nov 20.

37.

In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.

Pashov AD, Calvez T, Gilardin L, Maillère B, Repessé Y, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S.

Haemophilia. 2014 Mar;20(2):176-84. doi: 10.1111/hae.12276. Epub 2013 Oct 14.

PMID:
24118514
38.

Bee Venom Phospholipase A2, a Good "Chauffeur" for Delivering Tumor Antigen to the MHC I and MHC II Peptide-Loading Compartments of the Dendritic Cells: The Case of NY-ESO-1.

Almunia C, Bretaudeau M, Held G, Babon A, Marchetti C, Castelli FA, Ménez A, Maillere B, Gillet D.

PLoS One. 2013 Jun 18;8(6):e67645. doi: 10.1371/journal.pone.0067645. Print 2013.

39.

Identification and frequency of circulating CD4(+) T lymphocytes specific to Benzylpenicillin in healthy donors.

Nhim C, Delluc S, Halgand F, de Chaisemartin L, Weaver RJ, Claude N, Joseph D, Maillère B, Pallardy M.

Allergy. 2013 Jul;68(7):899-905. doi: 10.1111/all.12173. Epub 2013 Jun 10.

PMID:
23751122
40.

Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors.

Castelli FA, Szely N, Olivain A, Casartelli N, Grygar C, Schneider A, Besse A, Levy Y, Schwartz O, Maillère B.

J Immunol. 2013 Jun 1;190(11):5757-63. doi: 10.4049/jimmunol.1300145. Epub 2013 May 1.

41.

The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.

Kerzerho J, Schneider A, Favry E, Castelli FA, Maillère B.

J Biol Chem. 2013 May 10;288(19):13370-7. doi: 10.1074/jbc.M112.427302. Epub 2013 Apr 3.

42.

Comment on "The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude".

Maillere B.

J Immunol. 2013 Mar 1;190(5):1895. doi: 10.4049/jimmunol.1290079. No abstract available.

43.

Human CD4 T cell epitopes selective for Vaccinia versus Variola virus.

Probst A, Besse A, Favry E, Imbert G, Tanchou V, Castelli FA, Maillere B.

Mol Immunol. 2013 Apr;53(4):453-9. doi: 10.1016/j.molimm.2012.10.011. Epub 2012 Nov 10.

PMID:
23147561
44.

Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.

Knapp B, Fischer G, Van Hemelen D, Fae I, Maillere B, Ebner C, Schreiner W, Bohle B, Jahn-Schmid B.

BMC Immunol. 2012 Aug 8;13:43. doi: 10.1186/1471-2172-13-43.

45.

Comment on "Frequency of epitope-specific naive CD4+ T cells correlates with immunodominance in the human memory repertoire".

Ascough S, Ingram RJ, Metan G, Maillere B, Doganay M, Ozkul Y, Kim LU, Ballie L, Moore S, Huwar TB, Sriskandan S, Altmann DM.

J Immunol. 2012 Jun 1;188(11):5205-6; author reply 5206. doi: 10.4049/jimmunol.1290018. No abstract available.

46.

FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies.

Zuidmeer-Jongejan L, Fernandez-Rivas M, Poulsen LK, Neubauer A, Asturias J, Blom L, Boye J, Bindslev-Jensen C, Clausen M, Ferrara R, Garosi P, Huber H, Jensen BM, Koppelman S, Kowalski ML, Lewandowska-Polak A, Linhart B, Maillere B, Mari A, Martinez A, Mills CE, Nicoletti C, Opstelten DJ, Papadopoulos NG, Portoles A, Rigby N, Scala E, Schnoor HJ, Sigurdardottir ST, Stavroulakis G, Stolz F, Swoboda I, Valenta R, van den Hout R, Versteeg SA, Witten M, van Ree R.

Clin Transl Allergy. 2012 Mar 9;2(1):5. doi: 10.1186/2045-7022-2-5.

47.

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

Godet Y, Fabre E, Dosset M, Lamuraglia M, Levionnois E, Ravel P, Benhamouda N, Cazes A, Le Pimpec-Barthes F, Gaugler B, Langlade-Demoyen P, Pivot X, Saas P, Maillère B, Tartour E, Borg C, Adotévi O.

Clin Cancer Res. 2012 May 15;18(10):2943-53. doi: 10.1158/1078-0432.CCR-11-3185. Epub 2012 Mar 8.

48.

Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.

Ru Z, Xiao W, Pajot A, Kou Z, Sun S, Maillere B, Zhao G, Ojcius DM, Lone YC, Zhou Y.

PLoS One. 2012;7(3):e32247. doi: 10.1371/journal.pone.0032247. Epub 2012 Mar 5.

49.

[The prediction of immunogenicity of therapeutic proteins].

Maillère B, Delluc S, Ravot G.

Med Sci (Paris). 2012 Jan;28(1):82-8. doi: 10.1051/medsci/2012281021. Epub 2012 Jan 27. Review. French.

50.

A simple competitive assay to determine peptide affinity for HLA class II molecules: a useful tool for epitope prediction.

Bernardeau K, Kerzhero J, Fortun A, Moreau-Aubry A, Favry E, Echasserieau K, Tartour E, Maillère B, Lang F.

J Immunol Methods. 2011 Aug 31;371(1-2):97-105. doi: 10.1016/j.jim.2011.06.018. Epub 2011 Jun 25.

PMID:
21729700

Supplemental Content

Loading ...
Support Center